Home | Log in or Sign Up for full access | Tracked Organizations | Recent Tracked Activities

Recent Activities

Activities between Nov. 16, 2024, 12:27 a.m. and Nov. 23, 2024, 12:27 a.m. from: Biomanufacturing Technologies.

Click on a document link to see the original source document. Click on the name of an organization to see more organization linkages and timelines.


Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology

Document Date: Nov. 21, 2024, 1:30 p.m. / Source: GlobeNewswire
Activity Class: CorporateFinanceActivity / Type: Investment / Region: United States
Investor: Target: Document Extract: JUPITER, Fla., Nov. 21, 2024 (GLOBE NEWSWIRE) - Dyadic International, Inc. (NASDAQ: DYAI) , a global biotechnology company, announced today that it has been awarded a $ 3 million grant from the Gates Foundation for the cell line development of monoclonal antibodies (mAbs) targeting respiratory syncytial virus (RSV) and malaria utilizing the company's proprietary C1 protein production platform to provide globally accessible treatment options for underserved populations.
Document Source: https://www.globenewswire.com/news-release/2024/11/21/2985204/0/en/Dyadic-Receives-3-Million-Grant-to-Develop-Cost-Effective-Monoclonal-Antibodies-for-RSV-and-Malaria-Using-C1-Platform-Technology.html (archive.org page / archive.org listing)


Sartorius Stedim Biotech opens new Center for Bioprocess Innovation in Marlborough, USA

Document Date: Nov. 21, 2024, 7:34 p.m. / Source: PR Newswire
Activity Class: LocationActivity / Type: Added
Location_Added_By: Location: Document Extract: Sartorius Stedim Biotech opens new Center for Bioprocess Innovation in Marlborough, USA.
Document Source: https://www.prnewswire.com/news-releases/sartorius-stedim-biotech-opens-new-center-for-bioprocess-innovation-in-marlborough-usa-302313512.html (archive.org page / archive.org listing)


AMGEN ANNOUNCES SENIOR EXECUTIVE RESEARCH APPOINTMENT

Document Date: Nov. 20, 2024, 9 p.m. / Source: PR Newswire
Activity Class: RoleActivity / Type: Starting / Region: Thousand Oaks
Role: Person: Organization: Document Extract: THOUSAND OAKS, Calif., Nov. 20, 2024 /PRNewswire/ - Amgen (NASDAQ: AMGN) today announced that Howard Chang, M.D., Ph.D., will join the company as senior vice president of Research, effective Dec. 16, 2024.
Document Source: https://www.prnewswire.com/news-releases/amgen-announces-senior-executive-research-appointment-302312094.html (archive.org page / archive.org listing)


AMGEN ANNOUNCES SENIOR EXECUTIVE RESEARCH APPOINTMENT

Document Date: Nov. 20, 2024, 9 p.m. / Source: PR Newswire
Activity Class: RoleActivity / Type: Starting
Role: Person: Organization: Document Extract: AMGEN ANNOUNCES SENIOR EXECUTIVE RESEARCH APPOINTMENT.
Document Source: https://www.prnewswire.com/news-releases/amgen-announces-senior-executive-research-appointment-302312094.html (archive.org page / archive.org listing)


AMGEN ANNOUNCES SENIOR EXECUTIVE RESEARCH APPOINTMENT

Document Date: Nov. 20, 2024, 9 p.m. / Source: PR Newswire
Activity Class: RoleActivity / Type: Starting / Region: Thousand Oaks
Role: Person: Organization: Document Extract: THOUSAND OAKS, Calif., Nov. 20, 2024 /PRNewswire/ - Amgen (NASDAQ: AMGN) today announced that Howard Chang, M.D., Ph.D., will join the company as senior vice president of Research, effective Dec. 16, 2024.
Document Source: https://www.prnewswire.com/news-releases/amgen-announces-senior-executive-research-appointment-302312094.html (archive.org page / archive.org listing)

Archive.org page links will work if the page has already been archived by archive.org, but we can't guarantee which pages archive.org has archived so far.

Treat sameAsNameOnly relationship as same? No (Turn On)

Site Stats | About (includes privacy and cookie notices)
(c) by 1145, 2023-2024. Data licensed under the Open Database License. Please send an email if you need a non-share-alike license and/or you need API access.